Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#172 in Cambridge
#3,872 in United Kingdom
Discuva Limited
Forward Citations = 3
17 inventors:
Discuva Limited
% Expired Patents = 25.0
EPO Patents = 5
Forward Citations = 3
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
David Hugh Williams (3 out of 7 patents)
Arthur Keith Turner (3 out of 6 patents)
Paul Meo (1 out of 1 patent)
4. Mohammed Nawaz Khan (1 out of 2 patents)
5. Cedric Charrier (1 out of 1 patent)
6. Jean-Francois Carniaux (5 patents)
7. Anil Srivastava (4 patents)
8. Suresh Kumar (0 patent)
9. Gulsham Kumar (0 patent)
10. Alan Bye (0 patent)
11. Purushotham Vandanapu (0 patent)
12. Vijaya Reddy (0 patent)
13. Akhil Mahajan (0 patent)
14. Elena Bernadette Monika Breidenstein (0 patent)
15. Dipal Bhowmik (0 patent)
4 patents:
Company Overview
Discuva Limited is a biotechnology company specializing in the discovery of novel antibiotics to combat drug-resistant bacteria. Their innovative platform integrates cutting-edge technologies to identify and develop new therapeutic options for infectious diseases. With a focus on addressing the global health threat posed by antibiotic resistance, Discuva is dedicated to advancing the field of antibacterial drug discovery.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Discuva Limited. Retrieved from https://idiyas.com/company/discuva
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]